The Lancet Respiratory Medicine in conversation with

Corticosteroids, COPD, asthma and COVID-19

September 25, 2020 The Lancet
The Lancet Respiratory Medicine in conversation with
Corticosteroids, COPD, asthma and COVID-19
Show Notes

Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv